Search Results - "FINKLER, Neil J"

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study by Coleman, Robert L, Sill, Michael W, Lankes, Heather A, Fader, Amanda Nickles, Finkler, Neil J, Hoffman, James S, Rose, Peter G, Sutton, Gregory P, Drescher, Charles W, McMeekin, D. Scott, Hu, Wei, Deavers, Michael, Godwin, Andrew K, Alpaugh, R. Katherine, Sood, Anil K

“…Abstract Objectives Aflibercept targets vascular endothelial growth factor and placental growth factor. We evaluated activity and toxicity of aflibercept in…”
Get full text

Cellular therapy for ovarian cancer: experimental and clinical perspectives by Ingersoll, Susan B, Ahmad, Sarfraz, Finkler, Neil J, Edwards, John R, Holloway, Robert W

“…Ovarian cancer is the leading cause of death among gynecologic malignancies and the 5th leading cause of cancer deaths for women in the United States…”
Get more information

Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer by DeNardis, Sara A, Holloway, Robert W, Bigsby, Glenn E, Pikaart, Dirk P, Ahmad, Sarfraz, Finkler, Neil J

“…Abstract Objective To compare surgical morbidity and clinical–pathologic factors for patients with endometrial cancer (EC) undergoing robotic-assisted…”
Get full text

Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer by Dizon, Don S, Damstrup, Lars, Finkler, Neil J, Lassen, Ulrik, Celano, Paul, Glasspool, Ros, Crowley, Elizabeth, Lichenstein, Henri S, Knoblach, Poul, Penson, Richard T

“…Preclinical data show that belinostat (Bel) is synergistic with carboplatin and paclitaxel in ovarian cancer. To further evaluate the clinical activity of…”
Get more information

Impact of colorectal surgeon case volume on outcomes and applications to quality improvement by Yi, David, Monson, John R. T., Stankiewicz, Cathy C., Atallah, Sam, Finkler, Neil J.

“…Purpose To evaluate the impact of surgeon case volumes on procedural, financial, and clinical outcomes in colorectal surgery and apply findings to improve…”
Get full text

Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging by Backes, Floor J, Brudie, Lorna A, Farrell, M. Ryan, Ahmad, Sarfraz, Finkler, Neil J, Bigsby, Glenn E, O'Malley, David, Cohn, David E, Holloway, Robert W, Fowler, Jeffrey M

“…Abstract Objective Although intra-operative and immediate postoperative complications of robotic surgery are relatively low, little is known about long-term…”
Get full text

Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance by Holloway, Robert W, Ahmad, Sarfraz, DeNardis, Sara A, Peterson, Lorna B, Sultana, Nazia, Bigsby, Glenn E, Pikaart, Dirk P, Finkler, Neil J

“…Abstract Objectives To provide an objective analysis of surgical performance of robotic-assisted laparoscopic hysterectomy (RALH) with lymphadenectomy for…”
Get full text

Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery by Brudie, Lorna A, Backes, Floor J, Ahmad, Sarfraz, Zhu, Xiang, Finkler, Neil J, Bigsby, Glenn E, Cohn, David E, O'Malley, David, Fowler, Jeffrey M, Holloway, Robert W

“…Abstract Objectives To evaluate recurrence-free survival (RFS) and overall survival (OS) for patients who underwent robotic-assisted laparoscopic hysterectomy…”
Get full text

The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer by Gubbi, Ajit, Kendrick, James E, Finkler, Neil J

“…The majority of women with ovarian cancer will experience a recurrence of their disease despite aggressive primary cytoreduction and adjuvant cytotoxic…”
Get full text

Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer by Ingersoll, Susan B., Ahmad, Sarfraz, McGann, Hasina C., Banks, Robert K., Stavitzski, Nicole M., Srivastava, Milan, Ali, Ghazanfar, Finkler, Neil J., Edwards, John R., Holloway, Robert W.

“…Studies have shown enhanced survival of ovarian cancer patients in which the tumors are infiltrated with tumor infiltrating lymphocytes and natural killer…”
Get full text

Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer by Vergote, Ignace, Finkler, Neil J, Hall, James B, Melnyk, Ostap, Edwards, Robert P, Jones, Marsha, Keck, James G, Meng, Lisa, Brown, Gail L, Rankin, Elaine M, Burke, James J, Boccia, Ralph V, Runowicz, Carolyn D, Rose, Peter G

“…To evaluate the safety and efficacy of canfosfamide in combination with pegylated liposomal doxorubicin (PLD) in platinum-resistant ovarian cancer (OC)…”
Get more information

Metastatic Choriocarcinoma in a Viable Intrauterine Pregnancy Treated with EMA-CO in the Third Trimester: A Case Report by BRUDIE, Lorna A, AHMAD, Sarfraz, RADI, Michael J, FINKLER, Neil J

“…Choriocarcinoma is a highly malignant tumor arising from any gestation. Several cases of metastatic choriocarcinoma have been reported in the literature during…”
Get full text

Corrigendum to “A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study” [Gynecol Oncol 127 (2012) 538–543] by Coleman, Robert L, Sill, Michael W, Lankes, Heather A, Fader, Amanda Nickles, Finkler, Neil J, Hoffman, James S, Rose, Peter G, Sutton, Gregory P, Drescher, Charles W, McMeekin, D. Scott, Hu, Wei, Deavers, Michael, Godwin, Andrew K, Alpaugh, R. Katherine, Sood, Anil K

Get full text

Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients by Ingersoll, Susan Blaydes, Stoltzfus, Gregory P, Merchant, Mohammed H, Ahmad, Sarfraz, Edwards, Collin R, Ahmed, Ahad, Oyer, Jeremiah L, Finkler, Neil J, Holloway, Robert W, Edwards, John R

“…Abstract Background/Aims The aim of this study was to compare the cytotoxic response against ovarian cancer (OC) cells elicited by different immune effector…”
Get full text

Clinical–pathologic and morbidity analyses of Types 2 and 3 abdominal radical hysterectomy for cervical cancer by Pikaart, Dirk P, Holloway, Robert W, Ahmad, Sarfraz, Finkler, Neil J, Bigsby, Glenn E, Ortiz, B. Hannah, DeNardis, Sara A

“…Abstract Objective To provide representative data analyses of surgical morbidity and clinical–pathologic factors for Types 2 and 3 abdominal radical…”
Get full text

Functional characterization of a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in experimental models by Ingersoll, Susan Blaydes, Ahmad, Sarfraz, Stoltzfus, Gregory P, Patel, Sheylan, Radi, Michael J, Finkler, Neil J, Edwards, John R, Holloway, Robert W

“…The objective of this study was to functionally characterize a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in combination with…”
Get more information

Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery by Brudie, Lorna A., Gaia, Giorgia, Ahmad, Sarfraz, Finkler, Neil J., Bigsby, Glenn E., Ghurani, Giselle B., Kendrick, James E., Rakowski, Joseph A., Groton, Jessica H., Holloway, Robert W.

“…We analyzed peri-operative outcomes of 80 patients who underwent robotic-assisted laparoscopic surgery and were diagnosed with stage IV endometriosis (revised…”
Get full text

Association between in Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer Patients by Holloway, Robert W., Mehta, Rita S., Finkler, Neil J., Li, Kuo-Tung, McLaren, Christine E., Parker, Ricardo J., Fruehauf, John P.

“…Objective. The initial clinical response to platinum is a major determinant of outcome for patients with ovarian cancer. This retrospective study was…”
Get full text

Comparison of Total Laparoscopic and Abdominal Radical Hysterectomy for Patients With Early-Stage Cervical Cancer by Holloway, Robert W., Finkler, Neil J., Pikaart, Dirk P., Bigsby, Glenn E., DeNardis, Sara A., Ahmad, Sarfraz

Get full text

Metastatic Appendiceal Mucinous Adenocarcinoma to Well-Differentiated Diffuse Mesothelioma of the Peritoneal Cavity: A Mimicker of Florid Mesothelial Hyperplasia in Association With Neoplasms by Tran, Tien Anh N, Holloway, Robert W, Finkler, Neil J

“…Atypical/florid mesothelial hyperplasia associated with another neoplastic process is not an infrequent phenomenon and has been reported in a variety of…”
Get full text